Dmitry Zamoryakhin
Chief Tech/Sci/R&D Officer at BIODEXA PHARMACEUTICALS PLC
Profile
Dmitry Zamoryakhin is currently the Chief Scientific Officer at Biodexa Pharmaceuticals Plc since 2021.
Prior to this, he worked as the Chief Medical Officer at Oxford Biomedica Plc from 2018 to 2021 and as the Head-Development Strategy & Intelligence at Grünenthal GmbH from 2016 to 2018.
Dr. Zamoryakhin holds an MBA and a doctorate from Warwick Business School and a doctorate from Perm State Medical University.
Dmitry Zamoryakhin active positions
| Companies | Position | Start |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 11/07/2021 |
Former positions of Dmitry Zamoryakhin
| Companies | Position | End |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/08/2018 |
Training of Dmitry Zamoryakhin
| Warwick Business School | Doctorate Degree |
| Perm State Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
- Stock Market
- Insiders
- Dmitry Zamoryakhin
